Effect of POCO on Gastric Function in HV
NCT03682835 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2018-09-25
Summary
This study aims to investigate changes in gastric motility (including gastric accommodation), nutrient volume tolerance, gastric emptying and gastrointestinal hormones in healthy volunteers after an acute intake of a combination of peppermint oil and caraway oil, compared to placebo. In addition, the effect of a combination of peppermint oil and caraway oil on appetite-related sensations and upper gastrointestinal symptoms will be assessed.
Gastric emptying rate will be assessed using a 13C breath test. Intragastric pressure (IGP) will be measured using high-resolution manometry in fasted state and during intragastric infusion of a nutrient drink (350 mL or until full satiation). Appetite-related sensations and gastrointestinal symptoms were rated during IGP measurements. Blood samples were collected to assess peptide hormone levels.
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
FDGard
capsule containing peppermint oil and caraway oil
- OTHER
-
Placebo
Placebo capsule containing cellulose
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Jan Tack, MD · UZ Leuven / KU Leuven
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-13
- Primary Completion
- 2018-06-01
- Completion
- 2018-06-01
Countries
- Belgium
Study Locations
More Related Trials
-
Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia
NCT03205319 ·Status: COMPLETED ·Phase: NA
-
The Effects of STW 5-II on Duodenal Mucosa and Symptoms in Functional Dyspepsia
NCT07198243 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Primary Care dySpEpsia rikkuNshiTo
NCT06482671 ·Status: RECRUITING ·Phase: PHASE3
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Motilitone on Gastric Motor Function in Healthy Volunteers
NCT01719575 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
NCT06931223 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects
NCT01677338 ·Status: COMPLETED ·Phase: PHASE2
-
Symptoms and Physiological Effects of Amara in Functional Dyspepsia
NCT05553587 ·Status: COMPLETED ·Phase: PHASE4
-
Abdominothoracic Muscular Tone in Functional Dyspepsia
NCT05417204 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.
NCT00308399 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating the Efficacy of "Digestive Aid" in Functional Dyspepsia
NCT06958952 ·Status: RECRUITING ·Phase: NA
-
Symptoms and Endoscopic Results in Consideration of Pretreatment
NCT00612404 ·Status: COMPLETED
-
Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia
NCT05718960 ·Status: RECRUITING ·Phase: NA
-
Open-Label Placebo for Functional Dyspepsia
NCT03745781 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms
NCT07272681 ·Status: NOT_YET_RECRUITING
-
Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia
NCT05199441 ·Status: COMPLETED ·Phase: PHASE4
-
Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia
NCT07196735 ·Status: RECRUITING
-
Monitoring Stomach Function With an Intragastric Balloon - a Pilot
NCT03500887 ·Status: COMPLETED ·Phase: NA
-
The Effect of Rikkunshito on Gastric Accommodation and Nutrient Volume Tolerance in Functional Dyspepsia
NCT03856294 ·Status: COMPLETED ·Phase: PHASE2
-
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
NCT00761358 ·Status: COMPLETED ·Phase: PHASE3
-
Gastric Pathophysiology in Diabetes
NCT06068114 ·Status: RECRUITING
-
Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
NCT04647955 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269 ·Status: RECRUITING ·Phase: PHASE4
-
G-POEM vs PEG-J in Gastroparesis Patients
NCT06372132 ·Status: RECRUITING ·Phase: NA
-
Duodenal Microbiota in Functional Dyspepsia
NCT06326918 ·Status: RECRUITING